JP2024525723A5 - - Google Patents
Info
- Publication number
- JP2024525723A5 JP2024525723A5 JP2024501737A JP2024501737A JP2024525723A5 JP 2024525723 A5 JP2024525723 A5 JP 2024525723A5 JP 2024501737 A JP2024501737 A JP 2024501737A JP 2024501737 A JP2024501737 A JP 2024501737A JP 2024525723 A5 JP2024525723 A5 JP 2024525723A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phe
- peptide inhibitor
- cyano
- bicyclic peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221854P | 2021-07-14 | 2021-07-14 | |
| US63/221,854 | 2021-07-14 | ||
| PCT/US2022/037202 WO2023288017A2 (en) | 2021-07-14 | 2022-07-14 | Bicyclic peptide inhibitors of interleukin-23 receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525723A JP2024525723A (ja) | 2024-07-12 |
| JP2024525723A5 true JP2024525723A5 (https=) | 2025-07-24 |
Family
ID=84920518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501737A Pending JP2024525723A (ja) | 2021-07-14 | 2022-07-14 | インターロイキン－２３受容体の二環式ペプチド阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240352073A1 (https=) |
| EP (1) | EP4370532A4 (https=) |
| JP (1) | JP2024525723A (https=) |
| KR (1) | KR20240034223A (https=) |
| CN (1) | CN117980320A (https=) |
| AR (1) | AR126457A1 (https=) |
| AU (1) | AU2022310347A1 (https=) |
| CA (1) | CA3226492A1 (https=) |
| MX (1) | MX2024000761A (https=) |
| TW (1) | TW202321275A (https=) |
| UY (1) | UY39858A (https=) |
| WO (1) | WO2023288017A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| WO2024155551A1 (en) * | 2023-01-16 | 2024-07-25 | Janssen Pharmaceutica Nv | Polycyclic peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| CN121794283A (zh) | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2025076414A1 (en) * | 2023-10-06 | 2025-04-10 | The Children's Medical Center Corporation | Compositions and methods for selecting a subject for inflammatory bowel disease treatment |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026041110A1 (zh) * | 2024-08-22 | 2026-02-26 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107206254B (zh) * | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| US10301371B2 (en) * | 2014-10-01 | 2019-05-28 | Protagonist Therapeutics, Inc. | Cyclic monomer and dimer peptides having integrin antagonist activity |
| MX384213B (es) * | 2015-07-15 | 2025-03-14 | Protagonist Therapeutics Inc | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. |
| JP7100034B2 (ja) * | 2016-12-06 | 2022-07-12 | シュティヒティング・ヴォール・デ・テクニシェ・ヴェテンシャッペン | 多環式ペプチド及びそれらの調製方法 |
| WO2019034866A1 (en) * | 2017-08-14 | 2019-02-21 | Bicyclerd Limited | BICYCLIC PEPTIDE LIGANDS CONJUGATES AND USES THEREOF |
| CN111712509A (zh) * | 2017-12-15 | 2020-09-25 | 詹森生物科技公司 | 作为sting激动剂的环状二核苷酸 |
| WO2020014646A1 (en) * | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2021007433A1 (en) * | 2019-07-10 | 2021-01-14 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
-
2022
- 2022-07-14 EP EP22842895.9A patent/EP4370532A4/en active Pending
- 2022-07-14 CN CN202280062001.1A patent/CN117980320A/zh active Pending
- 2022-07-14 US US18/579,033 patent/US20240352073A1/en active Pending
- 2022-07-14 CA CA3226492A patent/CA3226492A1/en active Pending
- 2022-07-14 TW TW111126553A patent/TW202321275A/zh unknown
- 2022-07-14 MX MX2024000761A patent/MX2024000761A/es unknown
- 2022-07-14 WO PCT/US2022/037202 patent/WO2023288017A2/en not_active Ceased
- 2022-07-14 UY UY0001039858A patent/UY39858A/es unknown
- 2022-07-14 JP JP2024501737A patent/JP2024525723A/ja active Pending
- 2022-07-14 AR ARP220101855A patent/AR126457A1/es unknown
- 2022-07-14 AU AU2022310347A patent/AU2022310347A1/en active Pending
- 2022-07-14 KR KR1020247004796A patent/KR20240034223A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525723A5 (https=) | ||
| JP2024525732A5 (https=) | ||
| JP2024525780A5 (https=) | ||
| JP2025134806A5 (https=) | ||
| US11634418B2 (en) | Amino acid compounds and methods of use | |
| JP2023511551A5 (https=) | ||
| JP2022540154A5 (https=) | ||
| TW202330013A (zh) | 介白素－２３受體之脂化肽抑制劑 | |
| JP2024525723A (ja) | インターロイキン－２３受容体の二環式ペプチド阻害剤 | |
| SG11202110624YA (en) | Itaconic acid derivatives and uses thereof in treating an inflammatory disease or a disease associated with an undesirable immune response | |
| CA3181676A1 (en) | Imidazopyridazines as modulators of il-17 | |
| Liu et al. | Synthetic approaches to the 2009 new drugs | |
| CN102264694B (zh) | 用于制备伏立诺他的方法 | |
| CN105801489B (zh) | 环烷基取代的咪唑衍生物 | |
| JP2021530477A5 (https=) | ||
| US20240010606A1 (en) | Fumarate derivatives and their medical use | |
| US11306098B2 (en) | Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors | |
| CN1215991A (zh) | 霉酚酸盐的包有肠溶衣的药物组合物 | |
| US20230399289A1 (en) | Itaconic acid derivatives | |
| US20190077775A1 (en) | Process for the preparation of trisodium (4-{[1s,3r)-1-([1,1'-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(n-petanoyl-n-{[2'-(1h-tetrazol-1-1d-5-yl)[1,1'-biphenyl]-4-yl]methyl}- l-valinate) and its polymorphs thereof | |
| JP7475055B2 (ja) | （ｓ）－３－アミノ－４－（ジフルオロメチレニル）シクロペンタ－１－エン－１－カルボン酸の合成法 | |
| CN114746394B (zh) | 一种芳基丙酸衍生物、药物组合物及其制备方法和应用 | |
| US7109224B2 (en) | Acyl guanidine compounds and use thereof | |
| WO2022090714A1 (en) | Novel compounds | |
| EP4634167A1 (en) | Substituted pyridines for use in treating or preventing inflammatory diseases or diseases associated with an undesirable immune response |